Close

votumumab (TAB-715)

DESCRIPTION CATALOG # SIZE PRICE
Anti-CTAA16.88 Therapeutic Antibody (HumaSPECT) TAB-715 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant human monoclonal antibody expressed in CHO binding to human tumor antigen CTAA16.88. Technetium (99mTc) votumumab is a human monoclonal antibody labelled with theradionuclide technetium-99m and was developed for the detection of colorectal tumors.
  • Target
  • Colon tumor-associated antigen (CTAA) 16.88
  • Type
  • IgG3 - kappa
  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
  • CAS
  • 148189-70-2
  • Trade name
  • humaspect
  • Molecular Weight
  • 359.270 kDa
  • Purity
  • >95.0%. Determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Size
  • 1mg
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

BACKGROUND

  • Introduction
  • Technetium (99mTc) votumumab is a human monoclonal antibody for the detection of colorectal tumors.
  • Keywords
  • tumor antigen CTAA16.88; CTAA16.88; CTAA

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us